High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses

DSpace Repository

High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses

Author: Metzelder, S. K.; Schroeder, T.; Finck, A.; Scholl, S.; Fey, M.; Goetze, K.; Linn, Y. C.; Kroeger, M.; Reiter, A.; Salih, H. R.; Heinicke, T.; Stuhlmann, R.; Mueller, L.; Giagounidis, A.; Meyer, R. G.; Brugger, W.; Voehringer, M.; Dreger, P.; Mori, M.; Basara, N.; Schaefer-Eckart, K.; Schultheis, B.; Baldus, C.; Neubauer, A.; Burchert, A.
Tübinger Autor(en):
Salih, Helmut Rainer
Published in: Leukemia (2012), Bd. 26, H. 11, S. 2353-2359
Verlagsangabe: Nature Publishing Group
Language: English
Full text: http://dx.doi.org/10.1038/leu.2012.105
ISSN: 0887-6924
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)